Saturday, 1 April, 2023
TopicCovid vaccines

Topic: Covid vaccines

11% of 69 crore eligible people have taken Covid precaution dose, says govt, blames waning fear

Slight rise in precaution dose coverage after vaccines were made free but govt officials cite ‘Covid surge in many countries’ to emphasise need to increase uptake.

BA.2.75 — new Covid variant detected in India a mystery, but could ‘have immune-escape property’

This Omicron sub-lineage may have increased ability to infect people who’ve been infected before, or are vaccinated, according to some scientists. However, there's no govt data on this.

DCGI approval in, but here’s why you can’t choose Corbevax as your booster just yet

Corbevax was, over the weekend, approved for heterologous use as a Covid booster shot by apex drug regulator Drugs Controller General of India.

Our take on WHO’s Covid deaths estimate, RBI rate hike, SC’s vaccine take — in 50 words

ThePrint view on the most important issues this week.

2nd Covid shot from Serum Institute, Rs 225/dose: All about Covovax, new jab approved for teens

Covovax, developed by US company Novavax & manufactured in India by Serum Institute, is a protein-based vaccine developed from SARS-CoV-2 strain.

The ZyCoV-D mystery: 3 months after arrival in Bihar, not a single Covid vaccine shot given

Covid vaccine developed by Zydus Lifesciences was approved for use in those aged 12 and above in September 2021. Centre ordered 1 crore doses last year & delivery began in February.

We can’t ‘boost’ our way out of the Covid pandemic for the long term

While the vaccine is effective at preventing severe disease, it is likely that boosters will become an annual shot. Here's the science behind it.

New Covid vaccine developed in Germany produces better immune response in cancer patients

Peptide-based vaccine CoVac-1 has been developed by researchers at University of Tübingen. They say it induces better T-cell immune response in immunocompromised patients.

Now, data proves Covid vaccines work. So trust science, make third dose easily accessible

ThePrint view on the most important issues, instantly.

DCGI gives emergency use approval to Biological E’s Corbevax vaccine for kids aged 12-18

It is the second Covid vaccine to get approval for use in children in India after Bharat Biotech's Covaxin.

On Camera


File photo of smog in Delhi. Some doctors have called air pollution a bigger threat than Covid-19.| Photo: Suraj Singh Bisht | ThePrint

Air quality is better but not enough to banish air purifiers. Here are options for your room & car

What’s the solution for people who cannot leave Delhi? Air purifiers from Dyson's expensive range to Xiaomi's affordable ones can be of help.

NFRA to conduct audit quality inspections of five audit firms

New Delhi, Nov 16 (PTI) The National Financial Reporting Authority (NFRA) will carry out audit quality inspections of five audit firms, including the...


The Defence Services Staff College in Wellington | Image credit:

In a first, six women officers to enter prestigious Defence Services Staff College

As many as 15 women appeared for the examination, out of which six were selected, including one who has made it to the course along with her husband. 

Why military is more for asserting political will, not just about controlling territory

No matter what tactics, doctrine, or weapon system is used, the objective of any war is to control territory, argues Gen. MM Naravane (retd). But it's politics that matters most.